Levels of HbA@c decreased in @ of the individual treatment groups , as follows : for the triple DMARD therapy + IM glucocorticoids treatment arm , -@ mmoles/mole ( -@ % ) ( P < @ ) , for the triple DMARD therapy + oral glucocorticoids treatment arm , -@ mmoles/mole ( -@ % ) ( P < @ ) , for the MTX treatment arm , -@ mmoles/mole ( -@ % ) ( P = @ ) , and for the HCQ treatment arm , -@ mmoles/mole ( -@ % ) ( P = @ ) .